Parnell Pharmaceuticals Holdings Revenue and Competitors
Estimated Revenue & Valuation
- Parnell Pharmaceuticals Holdings's estimated annual revenue is currently $12.3M per year.
- Parnell Pharmaceuticals Holdings's estimated revenue per employee is $144,247
- Parnell Pharmaceuticals Holdings's total funding is $20M.
Employee Data
- Parnell Pharmaceuticals Holdings has 85 Employees.
- Parnell Pharmaceuticals Holdings grew their employee count by 8% last year.
Parnell Pharmaceuticals Holdings's People
Name | Title | Email/Phone |
---|---|---|
1 | Snr. VP Global Production Animal | Reveal Email/Phone |
2 | VP, Regulatory | Reveal Email/Phone |
3 | VP Digital Technology | Reveal Email/Phone |
4 | SVP Finance | Reveal Email/Phone |
5 | SVP & President US Operations at Parnell - Living Science | Reveal Email/Phone |
6 | VP Digital Technology | Reveal Email/Phone |
7 | VP Strategic Marketing | Reveal Email/Phone |
8 | VP US Commercial Operations | Reveal Email/Phone |
9 | VP Quality | Reveal Email/Phone |
10 | VP New Product & Innovation | Reveal Email/Phone |
Parnell Pharmaceuticals Holdings Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $10.3M | 51 | 9% | N/A | N/A |
#2 | $24.7M | 123 | -6% | N/A | N/A |
#3 | $5.6M | 28 | -10% | N/A | N/A |
#4 | $26.7M | 133 | -4% | N/A | N/A |
#5 | $4.4M | 22 | -19% | N/A | N/A |
#6 | $74.6M | 371 | 9% | N/A | N/A |
#7 | $22.7M | 113 | 3% | N/A | N/A |
#8 | $12.3M | 85 | 8% | $20M | N/A |
#9 | $3.8M | 19 | 6% | N/A | N/A |
#10 | $5.6M | 28 | 12% | N/A | N/A |
What Is Parnell Pharmaceuticals Holdings?
Parnell is a fully integrated veterinary pharmaceutical company dedicated to finding animal health solutions that matter. With a world class FDA accredited manufacturing facility in Sydney and operations in the USA, Canada, Middle East and Asia-Pacific, Parnell is one of the few companies committed to continued development of innovative products at the highest standard. Parnell has market leading products in Dairy and Beef Cattle Reproduction and Osteoarthritis treatments for Dogs and Horses. Our R&D pipeline spans Cattle Reproduction, Cattle Mastitis, Anesthetics for Dogs & Cats, Laminitis treatment for Horses, and Orthopedic treatments for multiple species.
keywords:N/A$20M
Total Funding
85
Number of Employees
$12.3M
Revenue (est)
8%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Parnell Pharmaceuticals Holdings News
SYDNEY, Dec. 15, 2017 /PRNewswire/ -- Parnell Pharmaceuticals Holdings Ltd. (OTC PINK:PARNF) company Director, Robert Joseph is providing...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $20.9M | 92 | 1% | N/A |
#2 | $15.3M | 93 | 6% | N/A |
#3 | $20.5M | 93 | 3% | N/A |
#4 | $20.7M | 94 | 2% | N/A |
#5 | $17.8M | 99 | N/A | N/A |